Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with ...

Singapore, 27 March 2025 – The National Heart Centre Singapore (NHCS) has successfully introduced a percutaneous procedure (with a balloon and stent) that transforms how complications in ...

Cook Medical today announced a collaboration with Mendaera to create solutions for needle-based interventions with handheld ...

Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system.

Mobile units allow these procedures to be performed within the operative surgical environment, and have proven indispensable for percutaneous manipulations of the kidney and proximal collecting ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation ...

A new study could lead to more widespread use of imaging technique to improve survival and prevent complications.

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...